MyMedicalRecords Presents Personal Health Records in Federal Court
LOS ANGELES, CA--(Marketwired - Jun 23, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF), through its wholly owned subsidiary
MyMedicalRecords, Inc. (collectively, "MMR"), appeared Wednesday,
June 18 in the United States District Court, Central District of
California, where plaintiff MyMedicalRecords, Inc., and
defendant(s) Quest Diagnostics, Inc., Empty Jar, LLC f/k/a Jardogs,
LLC, Allscripts Healthcare Solutions, Inc., WebMD Health Corp. and
WebMD Health Services Group, appeared before the Honorable Otis D.
Wright, II to provide both the plaintiff's and the defendants'
tutorial of the technology at issue in the cases. MMR focused
its technology tutorial on the invention including a demonstration
of the technology as available on MyMedicalRecords.com. The
tutorials were designed to assist the Court in understanding the
nature and operation of the invention covered by the two MMR
Personal Health Record patents at issue in the litigation,
specifically, U.S. Patent Nos. 8,301,466 and 8,498,883. The
tutorials were part of the Markman proceedings designed to
interpret disputes in patent claim language. The Markman process
also includes the filing of opening, opposition and reply claim
construction briefs which will be the subject of a scheduled August
19th, 2014 Markman hearing before Judge Wright.
Attorneys for MMR made the presentation with MMR Chief Executive
Officer and patent inventor Robert H. Lorsch. During the
presentation, MMR showed the Court samples of its new
MyMedicalRecords Personal Health Record Kit which was created for
sale at retail following the signing of patent license and retail
sales agreements with retailers representing more than 40 million
customers starting this summer. The Company also plans on
announcing licensing and settlement agreements with PHR and EMR
vendors prior to an upcoming new business trip to Australia next
week.
In his presentation, Lorsch recounted his story as a cancer
survivor and the challenging environment in healthcare that existed
prior to 2005. As a result, he invented the comprehensive product
that now makes it possible for medical consumers to access, collect
and manage their medical records, including prescriptions, online
in a secure and private manner. The product is also designed to
achieve seamless interoperability with one consolidated medical
record for patients and all their family members regardless of the
number of physicians and the technology on the other end of the
PHR. He pointed out that MMR's technology provides patients, any
number of treating doctors, and other medical personnel (including
emergency room physicians and staff) access to complete, secure and
private medical information whenever and wherever it's needed from
anywhere in the world. MMR's technology, he noted, can reduce
healthcare costs, eliminate unnecessary duplicate testing and
delays in obtaining treatment, as well as other wasteful and
potentially dangerous practices facing patients.
In addition to providing background into the invention, Lorsch's
presentation also included an account of a family with multiple
family members including Charlie Brown, the family pet. Lorsch also
spoke of his own personal experience using the MyMedicalRecords PHR
to manage his health, and help avert an operation, by transmitting
his own emergency medical records when he was hospitalized not long
ago. His experience is described in detail on the MMRGlobal blog
Home from the Hospital which is available at
http://blog.mmrglobal.com/2013/11/25/home-from-the-hospital/.
MyMedicalRecords, Inc. is a practicing entity and a leading
provider of secure and easy-to-use Personal Health Records through
its MyMedicalRecords PHR, and MMRPro and MMRProPlus document
management and imaging systems for healthcare professionals. MMR
also offers MyEsafeDepositBox, which provides an online site to
securely store important legal, financial, insurance and other
important documents, as well as medical and personal health
information. MMR's global health information technology patent
portfolio includes U.S. Patent Nos. 8,121,855; 8,117,045;
8,117,646; 8,301,466; 8,321,240; 8,352,287; 8,352,288; 8,498,883;
8,626,532; 8,645,161 and 8,725,537, which collectively include over
275 issued claims, along with additional applications and
continuation applications pending. MMR has also received notice
from the United States Patent and Trademark Office that its 12th
domestic patent, U.S. Patent No. 8,768,725, is being issued, and a
Notice of Allowance, Serial No. 13/082,896, was recently received
for an additional patent. The most recent NOA represents MMR's
first Clinical Trials patent and includes 18 claims directed to
methods and systems that provide for self-reporting being used to
create Electronic Health Records for purposes including Clinical
Trials. Additionally, MMR has received issued patents and has
pending applications in 11 other countries or regional authorities
of commercial interest including Australia, Canada, Singapore, New
Zealand, Mexico, Hong Kong, China, Japan, South Korea, Israel, and
Europe.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. MMR's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, MMR acquired intellectual property biotech
assets that include anti-CD20 antibodies and data and samples from
its FavId™/Specifid™ vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit www.mmrglobal.com. View demos and video tutorials of MMR's
products and services at www.mmrtheater.com. Follow us at
Facebook.com/MMRGlobal and Twitter.com/mmrglobal.
Forward-Looking Statements All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property licenses, intellectual
property enforcement actions, infringement claims or litigation,
and future performance, management's expectations, beliefs,
intentions, estimates or projections, constitute "forward-looking
statements." Such forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause MMR's
actual results to be materially different from historical results
or from any results expressed or implied by such forward-looking
statements. Some can be identified by the use of words (and their
derivations) such as "need," "possibility," "potential," "intend,"
"offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain,"
"plan," and "continue," or the negative of these words. Actual
outcomes and results of operations and the timing of selected
events may differ materially from the results predicted, and any
reported results should not be considered as an indication of
future performance. Such statements are necessarily based on
assumptions and estimates and are subject to various risks and
uncertainties, including those relating to the possible invalidity
of the underlying assumptions and estimates and possible changes or
developments in economic, business, industry, market, legal and
regulatory circumstances and conditions and actions taken or
omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such
differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims
of intellectual property infringement and general intellectual
property litigation; our ability to maintain, develop, license,
monetize and protect our patent portfolio for both MMR's health IT
and biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection
with licensing our intellectual property; our ability to establish
and maintain strategic relationships; changes in our relationships
with our licensees; the risk MMR's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations;
the length of sales cycles and the installation process; the
market's acceptance of new product and service introductions;
competitive product offerings and promotions; changes in government
laws and regulations including the 2009 HITECH Act and changes in
Meaningful Use and the 2010 Affordable Care Act; future changes in
tax legislation and initiatives in the healthcare industry;
undetected errors in our products; the possibility of interruption
at our data centers; risks related to third party vendors; risks
related to obtaining and integrating third-party licensed
technology; risks related to a security breach by third parties;
risks associated with recruitment and retention of key personnel;
other litigation matters; uncertainties associated with doing
business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of
the date of this release and, except as required by applicable law,
does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new
information, future events or otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033